Full Press Release Details
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive Guides and Customization 2022-2026" report has been added to ResearchAndMarkets.com's offering.
COVID-19 Drives a surge in demand but what is the long term impact? The microbiology lab may disappear while multiplex takes center stage.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing but is spiking as an enormous C19Dx demand sweeps over the globe. Find out what the numbers are in this informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this report. A range of dynamic trends are pushing market growth and company valuations.
pathogen evolution and pandemics
biotechnology advances in genetics
the rise of rapid testing
Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
All report data is available in Excel format on request.
The report includes five year market forecasts.
1.1 Strategic Situation Analysis and Impact of COVID-19.
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
3 The Infectious Diseases - Market Analysis by Disease
3.1 HIV - Human Immunodeficiency Virus (AIDS)
3.2 HBV - Hepatitis B
3.3 HCV - Hepatitis C
3.4 HPV - Human papillomavirus
3.6 CTGC - Chlamydia/Gonorrhoea
3.8 MRSA - Methicillin-resistant Staphylococcus aureus
3.9 VRE - Vancomycin-resistant Enterococcus
3.10 Blood Screening
3.12 Pandemic Diagnostics
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Distributor and Reagent Supplier
4.1.5 Independent Testing Lab
4.1.6 Public National/regional lab
4.1.8 Physician Office Labs
4.1.10 Certification Body
4.2 The Clinical Laboratory Market Segments
4.2.1 Traditional Market Segmentation
4.2.2 Laboratory Focus and Segmentation
4.3 Industry Structure
4.3.1 Hospital Testing Share
4.3.2 Economies of Scale
4.3.2.1 Hospital vs. Central Lab
4.3.3 Physician Office Lab's
4.3.4 Physicians and POCT
5 Profiles of Key MDx Companies
5.1 1928 Diagnostics
5.2 Abacus Diagnostica
5.3 Abbott Laboratories
5.4 Accelerate Diagnostics
5.6 Ador Diagnostics
5.8 Akonni Biosystems
5.9 Altona Diagnostics
5.10 Alveo Technologies
5.11 Anatolia Geneworks
5.13 Applied BioCode
5.14 Assurance Scientific Laboratories
5.15 Aureum Diagnostics
5.16 Aus Diagnostics
5.17 Beckman Coulter Diagnostics
5.18 Becton, Dickinson and Company
5.21 BioFire Diagnostics (bioMerieux)
5.22 bioMerieux Diagnostics
5.23 Bio-Rad Laboratories, Inc
5.24 Bosch Healthcare Solutions GmbH
5.26 Cepheid (Danaher)
5.29 Credo Diagnostics Biomedical
5.31 Curetis N.V./Curetis GmbH
5.33 Diagenode Diagnostics
5.35 Diasorin S.p.A.
5.38 Eurofins Scientific
5.40 Fulgent Genetics
5.41 Fusion Genomics.
5.43 Genetic Signatures
5.44 GenMark Dx (Roche)
5.46 Grip Molecular Technologies
5.47 Hibergene Diagnostics
5.53 Janssen Diagnostics
5.56 LightDeck Diagnostics
5.60 Lumos Diagnostics
5.61 Mammoth Biosciences
5.62 Maxim Biomedical
5.63 Meridian Bioscience
5.64 Mesa Biotech (Thermo Fisher)
5.65 Millipore Sigma
5.67 Mobidiag (Hologic)
5.68 Molbio Diagnostics
5.71 Novel Microdevices
5.73 Oxford Nanopore Technologies
5.78 Primerdesign (Novacyt)
5.82 Quest Diagnostics
5.84 Randox Toxicology
5.85 Roche Molecular Diagnostics
5.86 Saw Diagnostics
5.89 Siemens Healthineers
5.94 Talis Biomedical
5.95 Thermo Fisher Scientific Inc.
5.97 Veredus Laboratories
5.101 XCR Diagnostics
5.102 YD Diagnostics
5.103 Zhejiang Orient Gene Biotech
6.1 Factors Driving Growth